The use of partial exchange blood transfusion and anaesthesia in the management of sickle cell disease in a perioperative setting: two case reports by Rhett Jaeckel et al.
CASE REPORT Open Access
The use of partial exchange blood transfusion
and anaesthesia in the management of sickle
cell disease in a perioperative setting:
two case reports
Rhett Jaeckel*, Matthias Thieme, Elke Czeslick, Armin Sablotzki
Abstract
Introduction: Homozygous sickle cell carriers have an increased perioperative mortality. Some indications may
justify an exchange blood transfusion to reduce the proportion of haemoglobin S. The advantages of general
blood transfusion in a perioperative setting have not been proven and thus remain controversial. It is not clear
whether reducing the proportion of haemoglobin S minimizes perioperative complications or whether patients
with sickle cell disease in a stable clinical condition benefit from an exchange blood transfusion in a perioperative
setting.
Case presentation: We report the case of two Angolan children aged 10 and 11 respectively, of African origin
with sickle cell anaemia who underwent surgery to treat chronic necrosis, fistula of the bones and bone
destruction. This presentation describes the perioperative course, including general anaesthesia. A partial exchange
blood transfusion decreased S-haemoglobin levels from 81% to 21% and simultaneously treated the anaemia.
Conclusion: There is a consensus that imbalances in homoeostasis, including operative procedures, can cause a
critical exacerbation of sickle cell disease. The case presented here illustrates a strategy for successfully managing
sickle cell disease in the perioperative period to minimize its complications. It is important for the anaesthesiologist
to carefully manage pulmonary gas exchange and to ensure sufficient tissue perfusion, balanced fluid resuscitation
and normothermia, while keeping in mind the level of organ impairment in order to prevent an acute
exacerbation of sickle cell disease.
We performed a partial exchange blood transfusion due to the following factors: high haemoglobin S-fraction,
anaemia, operating procedure at several sites, and difficult management of body temperature. Esmarch ischemia is
an established tool for preventing uncontrolled blood loss. There is no known contraindication for this, but atten-
tion must be paid to prevent uncontrolled tissue ischemia and acidosis. The use of regional anaesthesia should be
considered for postoperative pain management.
Introduction
Disturbances in haemoglobin synthesis are some of the
most common human hereditary disorders. There is an
increased prevalence among the African and Asian
populations, and more recently, immigration has led to
an increase in the incidence of this disorder in Europe
as well. In Germany, for example, there are currently an
estimated 1000 patients with sickle cell disease (SCD)
[1].
SCD is a haemoglobinopathy characterized by an
abnormal haemoglobin variant termed haemoglobin S
(HbS). HbS causes irreversible filamentous precipitation,
which causes red blood cells to change shape, which in
turn leads to circulation problems. Clinical symptoms
include relapsing ischemic episodes, chronic haemolysis
and a specific type of anaemia termed sickle cell anae-
mia. The cause of this hereditary disorder is a single
amino acid substitution in the haemoglobin protein.
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Heterozygous sickle cell carriers are relatively resistant
to malaria, but homozygous patients are in danger of
increased perioperative mortality and have a reduced life
expectancy. In particular, conditions such as hypother-
mia, hypoxia, acidosis and dehydration in the periopera-
tive period can cause an acute exacerbation of the
disease [2,3]. Therefore, perioperative treatment must
include measures to prevent these conditions, as well as
measures to ensure safe general anaesthesia for these at-
risk patients.
Case presentation
We report the case of a 10-year-old Angolan boy with
homozygous sickle cell anaemia. An international aid
organization sponsored the medical treatment for the
boy and his brother, who was one year older and who
also had SCD. Both boys are of African origin.
The two boys were admitted to our hospital because
of chronic necrosis at several sites and fistula of the
long bones. On admission, the boys were severely ill and
had been ravaged by the effects of chronic SCD. Their
heights and weights were below the 3rd percentile (com-
pared with children of Central Europe), and they had
muscle hypotrophy, signs of chronic hypoxia and
chronic hepatitis B. The 10-year-old had malaria quar-
tana, and his older brother had terminal renal insuffi-
ciency. Episodes of acute chest syndrome were not
reported for both of them.
The 10-year-old boy was unable to walk because of
multiple aseptic bone necrosis of the right tibia bone,
the left femur and the lower leg. Imaging revealed pseu-
darthrosis, a fractured left fibula and a completely
destroyed left tibia. An older healed fracture of his left
femur was malpositioned. The lower leg bones were
destroyed and could not be reconstructed, and an exar-
ticulation had to be performed at the knee joint. In
addition, multiple sequestrectomies had to be performed
on the patient. Due to a hard estimation of blood loss
and duration of the whole procedure, this kind of sur-
gery is considered high risk.
On admission, the boy had the following laboratory
parameters: severe anaemia, with 3.9 mmol/l haemoglo-
bin and a haematocrit of 0.19; a 14.7% increase in reti-
culocytes; and positive results for the HbS solubility test.
Haemoglobin high performance liquid chromatography
(HPLC) revealed an HbS fraction of 81.7%, HbA2 of
4.7% and HbF of 3.0%. The C-reactive protein level was
at 70.5 mg/litre. The overall bilirubin was 52 μmol/litre
and the direct (conjugated) bilirubin was 21 μmol/litre.
Hyponatraemia was 131 mmol/litre. The test for hepati-
tis B surface antigen was positive, as was the test for the
hepatitis B envelope antigen. The result of the hepatitis
B envelope antigen test was negative, but there was evi-
dence of Plasmodium malariae. Sonography showed
nodular parenchyma and cholecystitis. The boy weighed
22 kg.
During preoperative care, a partial exchange transfu-
sion was performed because of the high percentage of
HbS. The surgical risk was also valued as very high due
to his reduced health condition and multiple foci with
probable prolonged duration of surgery. Meanwhile,
blood loss was hard to estimate. One day before surgery,
1200 ml of blood (equivalent to 70% of his blood
volume) was removed via the femoral artery for over
200 minutes. The blood was replaced using red blood
cell concentrate and normal saline (1:2) This partial
exchange transfusion decreased the HbS fraction to
21.6%; afterwards, haemoglobin HPLC revealed that his
HbA2 was 7.4% and HbF was 1.9%. The haemoglobin
was 7.5 mmol/litre, and the hematocrit was 0.36.
On the day of the surgery, the boy received 3 mg of
Midazolam intravenously. The oxygen saturation was
monitored using pulse oximetry. His body temperature
was monitored via a rectal temperature sensor and was
kept stable within a tight range (37.0 ± 0.5°C) by
increasing the temperature of the operating room, use
of heat conduction with special equipment, and heat
convection (warm touch).
General anaesthesia with endotracheal intubation was
performed as total intravenous anaesthesia using Propo-
fol and Fentanyl. Cisatracurium was used as a muscle
relaxant. Surgery was performed with an arrest of the
blood supply around the thigh. The overall blood loss
during the procedure was approximately 600 ml and
was substituted using a balanced electrolyte solution,
hydroxyethyl starch, 1 transfusion unit of red blood cells
and 1 transfusion unit of fresh frozen plasma. Circula-
tion parameters were kept stable during the surgical
procedure. Conditions that could have triggered an
acute exacerbation of SCD, such as hypoxia, hypovole-
mia, hypothermia and hyperviscosity, were prevented by
monitoring his vital signs and maintaining them within
tight ranges. Anaesthesia from the beginning up to the
end of surgery lasted 80 minutes.
Postoperative care, including fluid management and
weaning off the respirator with extubation on the day of
the surgery, was provided by the hospital’s Pediatric
Intermediate Care Unit. Pain was managed using Para-
cetamol and Piritramid intravenously as needed.
After the surgery, the boy complained of a relapsing
upper abdominal pain. Laboratory parameters showed
increased markers for cholestasis. After an endoscopic
retrograde cholangiopancreatography, a cholecystectomy
was performed four weeks after the initial orthopaedic
surgery, which revealed severe cholecystitis. Without
further transfusions at the time of abdominal surgery,
the HbS fraction was 34.5%; HPLC revealed that HbA2
was 1.1% and HbF was 1.5%. The haemoglobin was
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7.1 mmol/litre, and the hematocrit was 0.35. Due to the
modest level of Hbs fraction, we planned a substitution
of blood loss. During cholecystectomy, which lasted for
45 minutes, one unit of red blood cell was transfused.
Table 1 presents the time course of haematological data
and surgical procedures.
Meanwhile, the boy’s 11-year-old brother was suffer-
ing from heterogeneous sickle cell disease with a lower
HbS fraction. On admission the boy had the following
haematological parameters: severe anaemia at only 2.0
mmol/litre haemoglobin and a haematocrit of 0.09.
HPLC revealed an HbS fraction of 32.3%, HbA2 of 2.3%,
and HbF of 1.1%. He had to undergo several surgeries,
including sequestrectomies, drilling of the medullary
cavity and implantation of special devices to release
antibiotics. Due to HbS fraction of 32.3%, we performed
a substitution rather than exchange of the blood he lost.
In the course of surgeries he lost a lot of blood, on the
order of his whole blood volume, which was substituted
successfully with red blood cells, fresh frozen plasma
and balanced electrolyte solution. Table 2 shows the
time course and haematological data for this boy.
On admission he suffered from severe renal insuffi-
ciency and had to be treated with dialysis. The boy
underwent a total of seven surgical procedures and did
not develop any complications known to be associated
with SCD. The surgeries lasted between 30 and 90 min-
utes. General anaesthesia was performed on the patients
as described previously.
Discussion
SCD is a hereditary haemoglobinopathy characterized by
a mutation in the b-globulin gene on chromosome 11.
This mutation leads to the synthesis of HbS, in which
the hydrophobic valine at position 6 of the 146-amino
acid haemoglobin protein is replaced by the hydrophilic
amino acid glutamine. This replacement changes the
structure of haemoglobin: It becomes destabilized and
tends to precipitate when deoxygenated. This in turn
causes erythrocytes to take on the typical sickle cell
shape and also increases membrane fragility. Dehydra-
tion due to an increased intracellular haemoglobin con-
centration increases HbS polymerization. In
homozygous sickle cell carriers, the HbS ranges from
75% to 95%. Such carriers have increased perioperative
mortality and a decreased life expectancy for the patient.
About 30% suffer from a rapid course. Heterozygous
sickle cell carriers produce both HbS and normal HbA
and are usually asymptomatic [1]. Because of their resis-
tance to Plasmodium falciparum, heterozygous carriers
are more resistant to malaria and have a selective advan-
tage in places where the disease is rampant [2].
Despite their uniform genotype, heterogeneous car-
riers have highly variable phenotypes. Relapsing capil-
lary obstruction causes ischemic damage in many
organs, which leads to aseptic bone sequestration,
chronic osteomyelitis, renal insufficiency and fibrotic
transformation of the spleen. This damage is accompa-
nied by loss of function, decreased resistance to infec-
tion, cutaneous ulceration, retinopathy, acute cerebral
and cardial circulatory disorders, fibrotic lung transfor-
mation and pulmonary hypertension. Acute life threa-
tening episodes occur when the carrier is affected by
haemolytic and pain crises, splenic sequestration, lung
problems (acute thoracic syndrome) and corpus caver-
nosum (priapismus). Because the erythrocytes affected
by SCD have shorter life cycles (< 21 days), carriers
suffer from chronic haemolysis accompanied by anae-
mia, hyperbilirubinemia and cholecystolithiasis. In fact,
the most common surgical procedures in patients suf-
fering from SCD are cholecystectomies and orthopae-
dic surgery [3,4].
Table 1 Patient 1: Time course of haematological data and procedures.
Day Hb [mmol/litre] Hk [%] HbS [%] Measure
Admission 3.5 18 81.7
day 2 4.0 20
day 8 7.5 36 Exchange transfusion
day 9 pre-surgery 6.4 30 21.6 Orthopaedic surgery
day 9 post-surgery 7.1 34 Transfusion of 1 unit red blood cell
day 13 6.3 32
day 16 7.1 33
Day 22 6.6 31
Day 28 6.6 31
Day 31 5.9 28
day 38 pre-surgery 6.0 28 34.2 Cholecystectomy
day 38 post-surgery 6.7 31 transfusion of 1 unit red blood cell
day 56 discharge 5.6 27
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In addition to classical triggers, the activation of
endothelial factors, immunological responses and other
factors modulate the onset and course of the disease and
influence its pathophysiology. Nevertheless, there is a
consensus that imbalances in homoeostasis can cause cri-
tical exacerbation of SCD. For that reason, it is essential
to maintain normovolemia, normothermia and normoxe-
mia during anaesthesia and the perioperative period [5,6].
The clinical symptoms of SCD, which start in early
childhood, are splenomegaly, haemolytic anaemia and
relapsing pain. A diagnosis of SCD can be confirmed
using electrophoresis or chromatography [7]. Before
elective surgery, it is important to quantify SCD-related
parameters and determine whether organ insufficiencies
exist. Parenteral substitution with balanced electrolyte
solutions before surgery prevents dehydration and the
use of balanced volume substitution prior to surgery
and until ingestion is possible can avoid asymptomatic
fluid deficiencies. In cases of longer procedures with
increased fluid shifts, a urinary catheter is indicated to
monitor urinary volume. Hypoxemia due to hypoventila-
tion must be avoided by way of adequate monitoring
throughout the perioperative period, and benzodiaze-
pines should be given to reduce stress. Sufficient deni-
trogenization minimizes the risk of hypoxemia during
the induction of anaesthesia. There is no evidence that
alkalinization or intraoperative hyperoxygenation with
prolonged oxygen administration after surgery provides
any benefit.
Just as hypothermia can be harmful because of
increased viscosity, vasoconstriction and the resulting
increased oxygen consumption and hyperthermia can
escalate precipitation, thus jeopardizing the patient’s
condition. Therefore, the patient’s temperature must be
monitored constantly and measures must be taken to
prevent heat loss. In addition to basic haemodynamic
monitoring, pulmonary gas exchange must also be con-
tinuously monitored by spectrometric pulse oximetry
and capnometry. Depending on the clinical situation, an
artery catheter can be used to analyze blood gas and
monitor the haemoglobin level during the surgical
procedure.
Because patients with SCD generally have a history of
chronic pain and thus a history of using analgesics,
some may have a tolerance to opioids. When anaesthe-
sia is no longer needed, optimal fluid balance, analgesia,
normothermia and sufficient spontaneous breathing
activity are essential preconditions both for extubation
and to prevent dangerous shivering during postoperative
care. Postoperative care should ideally be given in an
intermediate or intensive care unit.
For individuals with SCD, Repeated blood transfusions
can reduce the frequency of ischemic complications
(especially strokes) and adolescence retardation [8]. The
degree to which HbS is reduced seems to generally cor-
relate with reduced complication rates [9]. Based on
pathophysiology and clinical experience, the substitution
of oxygen carriers and reduction of HbS below 30% to
Table 2 Patient 2: Time course of haematological data and procedures
Hb [mmol/l] HK [%] HbS [%] Measure
2.0 0.09 32.3 Transfusion of 3 units of red blood cells
4.8 0.25
5.3 0.24 Transfusion of 2 units of red blood cells
5.0 0.24 Start dialysis, transfusion of 2 units of red blood cells
6.9 0.31
5.6 0.27 Sequestrectomy tibia, transfusion of 2 units of red blood cells
5.5 0.26
4.6 0.22 Sequestrectomy femur, transfusion of 1 unit of red blood cell
4.9 0.22 Transfusion of 2 units of red blood cells
6.6 0.31 Sequestrectomy humerus, transfusion of 1 unit of red blood cell
5.6 0.27
5.0 0.23 Debridement tibia, transfusion of 2 units of red blood cells
5.4 0.26
4.5 0.23 Debridement humerus, transfusion of 1 unit of red blood cell
3.7 0.18 Transfusion of 2 units of red blood cells
5.3 0.25 Debridement humerus, transfusion of 1 unit of red blood cell
4.4 0.21 General anaesthesia to insertion of central venous line
3.9 0.18 Transfusion of 1 unit of red blood cell
5.2 0.24
Jaeckel et al. Journal of Medical Case Reports 2010, 4:82
http://www.jmedicalcasereports.com/content/4/1/82
Page 4 of 6
40% is recommended [6,10]. The advantages of blood
transfusions have not been proven and thus remain con-
troversial [5]. Koshy et al. described a statistically signif-
icant reduction of SCD-dependent complications from
12.9% to 4.8% using blood transfusions [4], and Neu-
mayr et al. reported that transfusions decreased compli-
cations from 18% to 9% [11]. In contrast, Vichinsky et
al. [3] compared aggressive exchange blood transfusion
(which reduced HbS to < 30%) to a conservative transfu-
sion regime (which increased haemoglobin to 6.3 mmol/
litre) and found out that the complication rate (which
was about 15%) did not differ. However, transfusion-
associated complications in patients who receive aggres-
sive exchange blood transfusions were 50% higher than
in patients receiving conservative transfusions. An analy-
sis of patients undergoing cholecystectomies and ortho-
paedic procedures indicated that an aggressive
transfusion regime is not always advantageous [12].
Thus, the physician must consider whether transfusion
associated complications, especially alloimmunization
and increased ferrous load, might increase the perio-
perative risks to an unacceptable level [3].
It is not clear whether reducing the proportion of HbS
minimizes perioperative complications, or whether
patients with SCD in a stable clinical condition benefit
from an exchange blood transfusion in the perioperative
setting. In particular, there is no positive indication that
exchange blood transfusion in patients undergoing
minor surgery and who have adapted rather well to
chronic anaemia can minimize complications. Our sec-
ond case demonstrates this fact impressively. SCD asso-
ciated complications were successfully avoided by the
substitution of perioperative blood loss with red blood
cells. Some indications, such as cerebral infarction,
occlusion of the mesenteric arteries and tolerance to
analgesia before a major surgery may justify an exchange
blood transfusion to reduce the proportion of HbS to
below 30% [1,6,10].
Reports in the literature do not show that one anaes-
thesia technique is better than others. Koshy et al.
reported an increased incidence of complications using
regional anaesthesia, but this was likely due to the high-
risk obstetric patient population [4]. Other researchers
did not find an increased risk with regional anaesthesia
when performed according to the same safety standards
used for general anaesthesia [13].
Esmarch ischemia is an established tool for prevent-
ing uncontrolled blood loss and was used in the ortho-
paedic surgery described in this case report. There is
no known contraindication for this, but attention must
be paid to prevent uncontrolled tissue ischemia and
acidosis [14].
Conclusions
SCD is a common hereditary affliction that is more
widespread among peoples in sub-Saharan Africa.
Increased population migration has increased the preva-
lence of this disease in other countries as well. SCD
causes progressive damage to multiple organs. Although
the concept of classical SCD triggers is less important
today, the effect of the disease on the carrier’s vascular
system determines the aetiology of the disease.
Patients are at risk in the perioperative period because
the physiological environment is disrupted. Thus, in
order to prevent an acute exacerbation of SCD, the
anaesthesiologist should carefully manage pulmonary
gas exchange, ensure sufficient tissue perfusion,
balanced fluid resuscitation and normothermia, and
keep in mind the level of organ impairment. The use of
regional anaesthesia should be considered for postopera-
tive pain management, and preoperative transfusions
can reduce ischemic complications during chronic
treatment.
In this case we performed a partial exchange blood
transfusion due to high HbS fraction, operating proce-
dure at several sites, and a body temperature that was
difficult to manage. Intraoperative blood transfusion
should be used to compensate for blood loss and reduce
anaemia. The case presented here illustrates a strategy
for successfully managing SCD in the perioperative per-
iod that would minimize complications.
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